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Abstract
Different parts of the genome occupy specific compartments of the cell nucleus based on the gene content and the
transcriptional activity. An example of this is the altered nuclear positioning of the HLXB9 gene in leukaemia cells observed
in association with its over-expression. This phenomenon was attributed to the presence of a chromosomal translocation
with breakpoint proximal to the HLXB9 gene. Before becoming an interesting gene in cancer biology, HLXB9 was studied as
a developmental gene. This homeobox gene is also known as MNX1 (motor neuron and pancreas homeobox 1) and it is
relevant for both motor neuronal and pancreatic beta cells development. A spectrum of mutations in this gene are
causative of sacral agenesis and more broadly, of what is known as the Currarino Syndrome, a constitutional autosomal
dominant disorder. Experimental work on animal models has shown that HLXB9 has an essential role in motor neuronal
differentiation. Here we present data to show that, upon treatment with retinoic acid, the HLXB9 gene becomes over-
expressed during the early stages of neuronal differentiation and that this corresponds to a reposition of the gene in the
nucleus. More precisely, we used the SK-N-BE human neuroblastoma cell line as an in vitro model and we demonstrated a
transient transcription of HLXB9 at the 4th and 5th days of differentiation that corresponded to the presence, predominantly
in the cell nuclei, of the encoded protein HB9. The nuclear positioning of the HLXB9 gene was monitored at different stages:
a peripheral location was noted in the proliferating cells whereas a more internal position was noted during differentiation,
that is while HLXB9 was transcriptionally active. Our findings suggest that HLXB9 can be considered a marker of early
neuronal differentiation, possibly involving chromatin remodeling pathways.
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Introduction
It is well know that the human genome is distributed in
organized structures that occupy specific areas of the nucleus
named chromosome territories [1]. Several studies have shown
that different parts of the genome occupy specific compartments of
the cell nucleus based on their gene content, with gene rich regions
positioned towards the nuclear interior and gene poor regions
positioned towards the periphery of the nucleus [1]–[6]. The
maintenance of higher order chromatin structure is crucial for the
maintenance of nuclear health and alterations of this equilibrium
are emerging factors in human diseases, including cancer [7]–[12].
Many studies also demonstrated that the chromatin arrangement
in the nucleus has a correlation with cellular functions, including
differentiation [13]–[19], and that gene distribution in different
regions of the nucleus is also associated with transcriptional activity
[20]–[26]. For instance, an altered nuclear positioning of the
HLXB9 gene was shown in leukaemia cells in association with
gene over-expression, a phenomenon that was attributed to the
presence of a chromosomal translocation with breakpoint prox-
imal to the HLXB9 gene [12].
The HLXB9 gene, also known as MNX1 (motor neuron and
pancreas homeobox 1), is located on chromosome 7q36.3 and
belongs to the family of EHG homeobox genes which includes also
EN1, EN2, GBX1 and GBX2 [27], [28]. HLXB9 is a gene of
12,801 bp, is composed of 3 exons and codes for a transcription
factor, HB9, formed by 401 aminoacids [29]. HB9 contains a
homeodomain, preceded by a highly conserved region of 82
amino acids (159–241) and a region of polyalanine that expands
from residue 121 to residue 134 in exon 1 [30].
HLXB9 was identified as a locus involved in the autosomal
dominant Currarino Syndrome, also known as Hereditary Sacral
Agenesis (HSA) syndrome: impaired function of the HLXB9 gene
generates a disorder characterized by rectal and uro-genital
malformations and sacral agenesis. Malformations observed in the
Currarino syndrome probably reflect disturbances in secondary
neurulation, a process that occurs in the early stages of
development [31].
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The HLXB9 gene is also involved in development of pancreatic
beta cell [29], [32] and motor neuronal cells with an essential role
in motor neuronal differentiation. Specific expression of HLXB9
in pancreatic beta cells is associated with the conserved function in
beta cells maturation. The gene is expressed in zebrafish and mice
during two different stages of pancreas development. Before the
embryonic stage of morphogenesis, HLXB9 is expressed in the
pancreatic endoderm, but with morphogenesis this gene is down-
regulated and subsequently reactivated during beta cells differen-
tiation. This makes the HLXB9 gene an early specific marker of
differentiation of pancreatic cells and suggests that this gene is
linked to the initial steps of beta cells specification [33].
RNA in situ hybridization experiments on the amphioxus
embryo have revealed that AmphiMnx (orthologue of the human
HLXB9 gene) has a dynamic pattern of expression in the
neuroectoderm and the mesoderm. The gene transcript is detected
ten hours after fertilization and decreases in the following hours
[34].
Moreover, HLXB9 is expressed during motor neuron differen-
tiation and it is part of the regulatory system for this process [35],
[36]. Genetic studies in the mouse highlight the importance of
HLXB9 in the consolidation and maintenance of motor neurons
identity suggesting that HLXB9 is to be considered a marker for
the correct development of spinal neurons. In fact, mice lacking
functional HLXB9 generate a correct number of motor neurons
but show dramatic changes in their program of differentiation,
such as: abnormalities in the pattern of migration, errors in the
motor axons projection and innervation defects in some target
muscles [35]. Moreover, studies performed on neuroepithelial
stem cells, showed an increase in the levels of HLXB9 transcripts
in motoneuronal phenotype [37].
Neuroblastoma cell lines have been used extensively as in vitro
models for studies on neuronal development including prolifera-
tion, differentiation and growth [38], [39], [40]. In particular, it
has been shown that it is possible to obtain neuron-like cells after
treatment with retinoic acid [38]. Being HLXB9 gene involved in
motor neuron identity, we wanted to investigate its expression
levels during neuronal cell differentiation, using the human
neuroblastoma cell line SK-N-BE as in vitro model, and its
nuclear location to point out a possible correlation between the
expression of HLXB9 and the chromatin re-organization, as
previously shown for this gene in leukaemic cells [12].
Here we demonstrate, for the first time, that HLXB9 is
expressed in a specific and restricted period during in vitro human
neuronal differentiation in the SK-N-BE neuroblastoma cell line,
and that HLXB9 expression is associated with a change of its
radial nuclear location, indicating HLXB9 as an early specific
marker of neuronal cell differentiation, a process that implies a
remodelling of the chromatin organization.
Materials and Methods
Cell cultures
Human neuroblastoma cell line SK-N-BE [38] grows in RPMI
1640 supplemented with fetal bovine serum (FBS) to a final
concentration of 10%, 1% antibiotic Penicillin/Streptomycin (P/
S) and 1% L-Glutamine at 37uC, with 5% CO2 [38]. SK-N-BE
cells were kindly gifted by Professor Della Valle from Department
of Genetics and Microbiology, University of Pavia, Italy [41].
Human myeloma U266 cells were kindly provided by Dr.
Daniele Tibullo, Department of Clinical and Molecular Biomed-
icine, University of Catania, Catania, Italy [42], purchased from
ATCC (code number TIB-196). Cells were maintained in RPMI
1640 medium supplemented with fetal bovine serum (FBS) to a
final concentration of 10%, 1% antibiotic Penicillin/Streptomycin
(P/S) and 1% L-Glutamine at 37uC, with 5% CO2 [43], [44].
Human liver cancer HepG2 cell line were kindly provided by
Professor Fabrizio Palitti, Department of Ecological and Biological
Sciences, University of Tuscia, Viterbo, Italy [45]. Cells were
grown in Dulbecco’s minimal essential medium (DMEM) supple-
mented with 15% fetal bovine serum, 1% antibiotic Penicillin/
Streptomycin (P/S) and 1% L-Glutamine at 37uC, with 5% CO2
[46].
SK-N-BE cells were differentiated in neuronal-like cells after
treatment with retinoic acid (10 mM). Retinoic acid was added to
the culture medium every 72 hours (day 0, 3, 6, 9) to obtain fully
differentiated cells at the 12th day of treatment [47], [48]. U266
and HepG2 cells were used as controls and treated with retinoic
acid (10 mM) for six days.
In situ hybridization on chromosomes and nuclei
To obtain metaphase chromosomes we added colcemid
0.05 mg/ml to the cell cultures for 1 hour before harvesting.
Then, cells were harvested in hypotonic solution (KCl 0.075 M)
and fixed with methanol-acetic acid (3:1). Interphase nuclei were
prepared using a protocol to preserve the 3D chromatin structure,
as previously described [49]. Briefly, cells were fixed in freshly
made 4% paraformaldehyde in PBS for 10 min, washed in PBS,
incubated in 0.5% Triton X-100 in PBS for 10 min, and
equilibrated in 20% glycerol in PBS for 30 min. Cells were then
frozen in liquid nitrogen and thawed at room temperature. After a
further wash in PBS, cells were incubated for 5 min in 0.1 N HCl.
Subsequently, fluorescence in situ hybridizations was performed
with PAC RPCI-5-1121A15 probe containing HLXB9 gene.
DNA probes were extracted using a commercial kit (Qiagen,
Milan, Italy), biotin-labeled by nick translation (Roche, Mann-
heim, Germany) and hybridized as previously described [6].
Detection of hybridized probe was performed using fluorescein-
conjugated avidin.
Statistical analysis
Images of the hybridized nuclei were captured using MacProbe
v4.3 software (Applied Imaging, Newcastle, UK), and radial
nuclear location of HLXB9 gene was obtained using the two-
dimensional (2D) analysis as previously described [6]. Briefly, the
radial nuclear position was first assigned to each hybridization
signal in each cell nucleus as a ratio of the nuclear radius (0 and 1
indicate the centre and the periphery of the nucleus, respectively)
using a dedicated computer software developed in our lab at the
University of Catania [6]. The assessment of each radial nuclear
location was based on the analysis of a minimum of 300 nuclei per
experiment. At least two different experiments per each examined
period (proliferative cells, and cells after 2, 4, 6, and 12 days of
treatment with retinoic acid) were performed. Nuclear location
was defined as the median value 6 confidence interval (C.I.):
median values lower than 0.65 indicate loci located more
internally in the nuclei. The statistical analyses were carried out
using Microsoft Excel and StatView softwares.
Expression analysis
To analyze gene expression in SK-N-BE cells, RNA was
extracted every day from 0 (start) to 12 days (fully differentiated
cells), after retinoic acid induction, using TRI Reagent (Sigma-
Aldrich, St. Louis, USA) and used in Real Time PCR experiments
(StepOne instrument from Applied Biosystems) with primers
specifically selected for target and control genes (Sigma-Aldrich,
St. Louis, USA) (Table 1). To analyze HLXB9 expression in the
control cell lines U266 and HepG2, RNA was extracted at day 0,
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4 and 6 after retinoic acid induction with the same conditions used
for SK-N-BE cells.
Real Time PCR was performed according to the manufacturer
instructions with specific annealing temperature and experiments
were repeated at least three times with statistical analyses for each
individual experimental set. A value of P,0.05 was considered
statistically significant. Data were represented as mean 6 standard
error of the mean (SEM). Data on HLXB9, GAP43, MAPT and
MYCN were analyzed using the Ct value. This is normalized with
Ct value of the endogenous control ACTB obtaining the DCt.
Normalizing the DCt of the sample of interest with that of the
calibrator, we get the DDCt. Finally, to determine the relative
concentration of the target gene in the sample of interest we
applied 22DDCt formula.
Immunolocalization
Indirect immunofluorescence experiments were performed on
SK-N-BE cells using anti HB9 antibody (Sigma–Aldrich, 1:100
dilution) at day 0, 4, 5 and 6 after retinoic acid treatment, and anti
b-tubulin antibody (Sigma–Aldrich, 1:100 dilution) at day 0 and
12. Cells were fixed with 4% paraformaldehyde for 20 min at
room temperature. Fixed cells were washed with PBS and
incubated 15 min in PBS containing 0.5% Triton X-100, and
then for 20 min in blocking solution. The cells were then
incubated with specific primary antibody overnight at 37uC. After
further PBS washes, the cells were incubated for 1 hour with anti-
rabbit secondary antibody conjugated with FITC (Invitrogen,
1:100) at 37uC. Photographs were taken under a Zeiss LSM 700
microscope.
Results
Assessment of differentiation in SK-N-BE cells
SK-N-BE cells treated with retinoic acid start differentiating
into neuronal-like cells. After 12 days of in vitro treatment, cells
are fully differentiated. During differentiation, cells stop prolifer-
ating and undergo multiple morphological modifications that
involve loss of round shape and development of cell protrusions to
resemble dendritic formations (Figure 1 A, B, C, D and E). Real-
time PCR experiments were performed on RNA samples
extracted from SK-N-BE cells on a daily basis during differenti-
ation, and specific markers to confirm neuronal differentiation
were used. These experiments showed expression of GAP-43 and
MAPT gene throughout the 12 days, with a dramatic increase at
day 12. Conversely, MYCN expression was higher at the initial
stages of retinoic acid treatment and decreases with time during
differentiation (Figure 1F).
HLXB9 gene expression in SK-N-BE
Real-time PCR showed the presence of HLXB9 mRNA mainly
in the fourth and fifth day of differentiation, then undergoing a
significant decrease on the sixth day and disappearing from
seventh to twelfth day of differentiation. Analysis of data obtained
from 22DDCt calculation enabled us to quantify the increase of
HLXB9 expression, with an eightfold increase at the fourth day
and a fivefold increase at the fifth day compared to proliferating
cells (Figure 2B).
To confirm that our observations are specific for the SK-N-BE
cell line and that retinoic acid itself does not influence HLXB9
gene expression we used two other different cell lines as control:
U266 and HepG2 cells, derived from myeloma and liver cancer
respectively. These cell lines, exposed to retinoic acid for six days,
did not show an increase in HLXB9 expression (Figure 2D).
HB9 immunodetection
In agreement with the Real time PCR data showing HLXB9
gene expression, the HB9 protein was detected in the SK-N-BE
cells at fourth and fifth day of differentiation by immunofluores-
cence with specific antibody. HB9 immunostaining was detected in
both nuclei and cytoplasm of cells at the fourth and fifth day of
differentiation, with more intense staining in the nucleus than in
the cytoplasm. This preferential nuclear location is compatible
with the function of HB9 protein as transcription factor. Cells at
sixth day of differentiation showed a decrease of the HB9 presence
in the nucleus (Figure 3).
Radial nuclear location of the HLXB9 gene
Using fluorescence in situ hybridization we assessed the
positioning of HLXB9 gene in the interphase nuclei of SK-N-
BE cells at proliferative stage, 2nd, 4th, 6th, and 12th day after
retinoic acid induction respectively. Our data showed that HLXB9
is localized to a more peripheral position in the proliferating SK-
N-BE nuclei with median values of 0.73 whereas it occupies a
more internal localization in SK-N-BE from 2nd day of
differentiation, with median values of 0.60. This internal location
of HLXB9 gene is conserved up to the 12th day of differentiation
(Figure 4).
Table 1. Primers used in the present study.
Human Gene Size Nucleotide sequence (59-39)
HLXB9 137 bp Forward AACCTCCTGGGGAAGTGC
Reverse GGTGAGCATGAGCGAGGT
ACTB 131 bp Forward GACGACATGGAGAAAATCTG
Reverse ATGATCTGGGTCATCTTCTC
GAP-43 76 bp Forward GAGGAAAAATCTTCAGAGACC
Reverse AACCCTTGAAATCCAGAAAG
MYCN 187 bp Forward GAGCGATTCAGATGATGAAG
Reverse TCGTTTGAGGATCAGCTC
MAPT 190 bp Forward CTGGTTTGGGTACAGTTAAAG
Reverse AGATCCCTTCAACTTAGGAG
doi:10.1371/journal.pone.0105481.t001
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Discussion
The expression levels of HLXB9 gene have been evaluated in
proliferating SK-N-BE cells and at different stages of their
neuronal differentiation, from day 1 to day 12 of treatment with
retinoic acid. Differentiation was assessed by observing the
morphological changes at the cellular level and was confirmed
by real time PCR experiments through the assessment of mRNA
levels of some known specific markers of differentiation such as
GAP-43, MAPT and MYCN genes [48], [50]–[53]. Our data
indicate that HLXB9 is only expressed during the fourth, and fifth
day from the start of differentiation, showing a decrease in the
following days and disappearing from the ninth day. Moreover, we
observed during differentiation a significant change in the HLXB9
gene nuclear positioning, from a peripheral location in the
proliferating cells to a more internal position during differentia-
tion.
These findings indicate that the HLXB9 gene is repositioned to
the inner part of the nucleus within 2 days of differentiation to start
its transcription, and then it maintains the more internal nuclear
position until the end of differentiation, in a down-regulated state.
Thus we can assume that HLXB9 gene in proliferating SK-N-BE
cells is maintained in a repressed status by chromatin compaction
at the nuclear periphery. Then, the retinoic acid treatment seems
to induce a chromatin reorganization that determines a reposi-
tioning of the genes in the nucleus, with HLXB9 relocated in a
more internal, and transcriptionally competent, compartment.
After the 5th–6th day, HLXB9 remains in the inner part of the
nucleus in a transcriptionally inactive status, probably due to the
Figure 1. Morphological changes and expression analysis of neuronal differentiation markers in SK-N-BE cells. (A, B, C) Morphology of
the SK-N-BE cells in proliferating stage (A), and at 6th (B) and 12th (C) day after treatment with retinoic acid. The cell body from relatively round shape
(A) becomes more elongated (B) and cells eventually form dendridic-like extensions (C). Images were obtained using the inverted microscope
Olympus CK40 (200x magnification). (D, and E) Dendridic-like extensions are clearly visible by indirect immunofluorescence experiments to detect b-
tubulin protein in SK-N-BE cells at the 12th day after treatment with retinoic acid (E) respect to the proliferating stage (D). These images were obtained
using the Zeiss LSM700 Confocal Laser Scanning Microscopy. (F) Histograms showing the expression profile of GAP-43, MYCN, and MAPT genes, three
control genes differently expressed during cell differentiation, reaching the peak of expression on the twelfth day (GAP-43 and MAPT), or on the early
days (MYCN), when SK-N-BE treated with retinoic acid are differentiated in a neuron-like form. 0 indicates proliferating cells before treatment with
retinoic acid.
doi:10.1371/journal.pone.0105481.g001
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absence of specific, unidentified, transcription factor, and/or
epigenetic modification of its regulatory region.
Previous studies carried out in human lymphocytes, showed that
chromosome 7 is arranged in a zig-zag manner with the gene-
poorest regions located close to the nuclear envelope [6]. In this
context, the 7q36.3 band, where the HLXB9 gene is mapped, has
a peripheral location. This is the case also in the proliferative SK-
N-BE cells, as shown in the present work. The peripheral location
is associated with the absence of expression of HLXB9. Our
findings suggest that the retinoic acid induction determines, from
the first addition, a chromatin remodeling which moves the
HLXB9 gene into a transcriptionally competent compartment,
toward the internal part of the nucleus. Thus, transcriptional
activation of HLXB9 could be considered a response of the SK-N-
BE cells to the retinoic acid.
Although an increases in HLXB9 expression was previously
observed in motor neurons derived from human stem cells [37],
our results show for the first time the change in expression level of
the gene during several days of human neuronal differentiation
Furthermore, HLXB9 expression was tested in relation to its
nuclear positioning in a neuronal model. Previous reports showed
alterations of gene positioning within the nucleus during develop-
ment. For instance, a change in the positioning of adipogenesis
genes corresponding to their expression implies a reorganization of
the nuclear architecture in the stem cells of pig embryos [54]. The
more internal positioning of the HLXB9 gene in the cell nucleus of
neuronal cells half way through differentiation, might be crucial
for its expression, making it more available to the transcription
machinery. It was previously observed that a change in nuclear
positioning for HLXB9 corresponded to an increase of its
transcriptional activity due to a chromosomal translocation in
leukaemia [12]. Our data indicate that HLXB9 expression is
related to the chromatin reorganization not only in the case of
Acute Myeloid Leukemia (AML), but also during neuronal
differentiation. Being HB9 a transcription factor itself [35], [36],
our findings suggest that this protein must be required only at a
certain time point during neuronal differentiation, in order to
initiate specific pathways conducive to cell maturity.
Our findings suggest that HLXB9 might have a functional role
in the differentiation process. Therefore, this gene could be
considered a marker of development and consolidation of motor
neuron, and more generally, as a marker of the early stages of
neuronal differentiation, also involving a chromatin remodelling
pathway, in addition to known markers that are found in
completely differentiated neurons such as GAP-43, NF, MAP2,
TAU [48], [50]–[53].
The possibility to use a human derived cell line has been an
advantage in this work, allowing us to highlight HLXB9
transcriptional activation in relation to the cell differentiation
process and to the chromatin reorganization. Therefore, SK-N-BE
cell line can be considered a good tool to study in vitro neuronal
development. The use of this model enabled us also to evaluate the
expression of other chromatin reorganization genes during the
different stages of cell differentiation. Further work is needed to
Figure 2. HLXB9 expression in SK-N-BE. (A) Amplification plot of
Real time PCR experiments. Data show HLXB9 expression in SK-N-BE
cells at different days after retinoic acid treatment in comparison with
expression of ACTB (Actin-B) used as a control. (B) Histogram generated
with values of 22DDCt. Samples are on x-axis and fluorescence emission
is on y-axis. The increase of HLXB9 expression in SK-N-BE cells is noted
dramatically on the fourth and fifth day of differentiation. Subsequently,
HLXB9 expression decreases until disappearing at day 12. (C)
Electrophoresis of the Real time PCR fragments obtained with the
specific primers for HLXB9 and for the control gene ACTB. Electropho-
resis of MYCN Real time PCR fragments was also shown. In B, and C ‘‘0’’
indicates proliferating cells before treatment with retinoic acid. D)
Histogram generated with values of 22DDCt. Samples are on x-axis and
fluorescence emission is on y-axis. There isn’t a significant increase of
HLXB9 gene expression in U266 and HepG2 cells, when cells are treated
with retinoic acid. Data in the graphs B, and D are represented as mean
6 standard error of the mean (SEM).
doi:10.1371/journal.pone.0105481.g002
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Figure 3. Indirect immunofluorescence to detect HB9 protein in SK-N-BE cells. A, B, C, and D show SK-N-BE cells at proliferative stage (day
0) and at 4th day, 5th day, and 6th day after acid retinoic induction respectively. HB9 protein (green signal) is visible in both nucleus and cytoplasm at
the fourth and fifth days of differentiation (B, C). A very faint staining is also noted in the cytoplasm of cells at proliferating stage (A) and in the
cytoplasm of cells at the sixth day of differentiation (D). A, B, C and D are the merge images of A’, B’, C’, D’, representing immunofluorescence staining
only, and A’’, B’’, C’’, D’’, representing the DAPI staining of the nucleus only in blue. Scale bar is 10 mm.
doi:10.1371/journal.pone.0105481.g003
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better understand the relevance of HLXB9 in the neuronal
differentiation program and to establish whether this gene could
be exploited to reprogram degenerative neuronal cells. These
aspects would have considerable implications in the therapy of
human conditions such as Alzheimer disease.
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